The recent emergence of nanomedicine has revolutionized the therapeutic landscape and
necessitated the creation of more sophisticated drug delivery systems. Polymeric …

Cardiovascular diseases (CVDs) present a significant threat to health, with traditional
pharmaceuticals for their treatment being hindered by inefficiencies due to non-targeted …

Rationale: Myocardial injury triggers intense oxidative stress, inflammatory response, and
cytokine release, which are essential for myocardial repair and remodeling. Excess reactive …

Chronic inflammation contributes to the pathogenesis of many diseases, including
apparently unrelated conditions such as metabolic disorders, cardiovascular diseases …

Targeting nanoparticle is a very promising therapeutic approach that can precisely target
specific sites to treat diseases. Research on nanoscale drug delivery systems has made …

Cardiac fibrosis is the excessive accumulation of extracellular matrix components in the
heart, leading to reduced cardiac functionality and heart failure. This review provides an …

Cardiovascular diseases are one of the leading global causes of morbidity and mortality,
posing considerable health and economic burden on patients and medical systems …

RNA therapeutics hold significant promise in the treatment of cardiovascular diseases.
RNAs are biologically diverse and functionally specific and can be used for gain-or loss-of …

Macrophages are involved in the whole process of atherosclerosis, which is characterized
by accumulation of lipid and inflammation. Presently, clinically used lipid-lowering drugs …

Metal selenide nanomaterials have received enormous attention as they possess diverse
compositions, microstructures, and properties. The combination of selenium with various …